COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes
Recruiting · 39 sites across 21 states
Always free
Study care at no cost to you
For your time and travel
Many studies pay you back
Most need no insurance or papers
Legal status usually isn't required; we'll tell you each study's requirements
Interpreters available
Ask for your language
Your choice
Voluntary — you can stop anytime
What is this study?
To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
It is , overseen by an independent and licensed medical staff.
Read the full clinical description
To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
Who this study is looking for
In plain language, from the study's own rules. The study team confirms the full details with you — this isn't a final yes or no.
✅ You may be able to join if…
- •Men and women aged 55 to 80 years
- •Have type 2 diabetes being treated according to national guidelines
- •Have no prior coronary artery disease–related clinical event
- •Have at least one high-risk factor such as long diabetes (5+ years), high HbA1c (≥8.0% in the last 2 years), active smoking, or certain abnormal heart/diabetes-related tests (like hs-CRP, coronary calcium score, or cholesterol levels)
- •Women who can get pregnant must have a negative urine pregnancy test and agree to effective birth control during the study
🚫 You may not be able to join if…
- •Have a prior history of heart attack, angina, coronary revascularization, coronary stenosis >30%, stroke, transient ischemic attack, or known heart failure
- •Have chronic kidney insufficiency with eGFR <35 mL/min/1.73m2
- •Have had cancer or a lymph node/blood cancer within the last 3 years (with some allowed exceptions for certain skin cancers and a few localized cancers)
- •Have inflammatory bowel disease (Crohn’s disease or ulcerative colitis) or chronic diarrhea
- •Are pregnant or breast-feeding (or trying to become pregnant) during the study or for 6 months after the last dose
Are you a good fit?
Simplified highlights. The study team always confirms the full details with you.
- ✓Adults roughly 55–80
- ✓Have Type 2 diabetes or Heart / cardiovascular disease or High cholesterol
- !Some conditions may not be a fit: Kidney disease
- !Not for people who are pregnant or breastfeeding
What to expect, step by step
- 1
Usually a few weeks
The study team checks whether the study is a good fit for you, with a visit and sometimes lab tests. You can ask any questions before deciding.
- 2
Treatment
If you join and choose to continue, you receive the study treatment and are watched closely by medical staff.
- 3
Follow-up
After treatment, the team checks on your health and confirms the visit schedule with you. You can leave the study at any point.
Has this treatment been tested before?
Yes. This treatment has already been through earlier human studies for safety before reaching this stage.
What you need to know before you apply
What is this study testing?+
To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
Is it safe? Who makes sure of that?+
This is a late-stage study (Phase 3), testing how well the treatment works in more people. Every study is reviewed and monitored by an independent ethics board (called an IRB) whose job is to protect participants, and care is overseen by licensed medical staff. You'll be told the known risks before you agree to anything, and you can stop at any time.
Will I get a placebo instead of the real treatment?+
Some studies compare a treatment against a placebo (an inactive version), and some don't. If this one does, the study team will explain your chances of receiving the active treatment before you decide. Nothing is hidden from you.
Do I have to stop taking my current medications?+
It depends on the study. Some let you stay on your current medications and some ask you to adjust them. Never stop a medication on your own — the study team will review everything with you first.
Does it cost anything? Will I be paid?+
The study treatment and study-related visits are provided at no cost to you. Some studies also pay for your time; the coordinator can tell you if this one does. You should never be asked to pay to take part.
Do I need insurance? Will anyone ask about my immigration status?+
No. You do not need health insurance to take part in a research study, and you will not be asked about your immigration status to join. Taking part is about whether you're a medical fit for the study.
What if English isn't my first language?+
You have the right to understand everything before you agree. Study sites can often provide materials or an interpreter in your language — you can ask the coordinator for one.
Is my information private?+
Yes. Your health information is only shared with the study sites you choose to be contacted by, and only to help match and enroll you. It is never sold, and you can ask us to delete it at any time.
Some requirements (like specific lab values or timing) are confirmed directly by the study team, not by us.
Source: ClinicalTrials.gov · NCT05633810 · Locations: Western Australia · Ontario · Quebec · Aveyron · Brittany Region · Gard · Haute-Garonne · Loire Atlantiue · New Aquitaine · Occitanie · Occtanie · Pays de la Loire Region · Seine-Saint-Denis · Yvelines · Apulia · Bari · Emilia-Romagna · Lombardy · Piedmont · The Marches · Tuscany